-
qualifications should include: PhD in Immunology or Cancer Biology: Backed by a strong publication record in peer-reviewed scientific journals. Translational Research Expertise: Proficiency in designing and
-
biomarkers Your qualifications should include: · Recent PhD graduate (within past 2 years) with a strong background and profound knowledge in the field of oncology, cancer biology, immunology
-
of biological/medical sciences with ambition for a scientific career and interest in DNA replication and repair, genome stability, and cancer biology and skills in molecular biology, genetics or biochemistry
-
. Human synthetic insulin, monoclonal antibodies and numerous breakthrough cancer drugs are based on technology developed at the institution. AccessHope™, a subsidiary launched in 2019 serves employers and
-
, immunology, and animal tumor models; design and conduct experiments; generate, analyze and evaluate data present results in an organized manner; learn new techniques and approaches; stay updated with latest
-
cell therapies and thymic function, spanning basic science to clinical trials. For more information about Dr. van den Brink’s research, please visit here . Lab's Philosophy : We foster a supportive and
-
). We are one of the few interventional oncology groups in the United States with a basic science lab, large animal tumor model, and several active clinical trials, which enables us to translate new